Mink Therapeutics Inc
NASDAQ:INKT
Mink Therapeutics Inc
NASDAQ:INKT
Price:
11.04
USD
-3.75%
Market Closed
Market Cap:
$51.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
Transformers and Rectifiers (India) Ltd
NSE:TRIL
|
IN |
|
Indo Tambangraya Megah Tbk PT
OTC:ITAYY
|
ID |
|
AutoCanada Inc
TSX:ACQ
|
CA |
|
Albemarle Corp
NYSE:ALB
|
US |
|
J
|
Jiangxi Tianli Technology INC
SZSE:300399
|
CN |
Balance Sheet
Balance Sheet Decomposition
Mink Therapeutics Inc
Mink Therapeutics Inc
Balance Sheet Decomposition is not available for
Mink Therapeutics Inc
Mink Therapeutics Inc
Balance Sheet
Mink Therapeutics Inc
Mink Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
3
|
39
|
20
|
3
|
5
|
13
|
|
| Cash Equivalents |
0
|
3
|
39
|
20
|
3
|
5
|
13
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
4
|
40
|
20
|
4
|
5
|
14
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Assets |
1
N/A
|
5
+248%
|
40
+782%
|
21
-47%
|
5
-79%
|
6
+26%
|
14
+149%
|
|
| Liabilities | ||||||||
| Accounts Payable |
2
|
3
|
3
|
6
|
4
|
3
|
3
|
|
| Accrued Liabilities |
3
|
2
|
2
|
4
|
5
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Other Current Liabilities |
2
|
10
|
12
|
3
|
2
|
2
|
3
|
|
| Total Current Liabilities |
7
|
14
|
16
|
13
|
11
|
7
|
13
|
|
| Long-Term Debt |
27
|
44
|
0
|
0
|
0
|
5
|
0
|
|
| Other Liabilities |
3
|
0
|
0
|
9
|
11
|
13
|
15
|
|
| Total Liabilities |
38
N/A
|
58
+55%
|
16
-72%
|
22
+33%
|
23
+3%
|
25
+12%
|
28
+12%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
37
|
53
|
83
|
111
|
133
|
144
|
157
|
|
| Additional Paid In Capital |
0
|
0
|
107
|
111
|
116
|
125
|
143
|
|
| Other Equity |
0
|
2
|
1
|
0
|
0
|
1
|
1
|
|
| Total Equity |
36
N/A
|
54
-48%
|
24
N/A
|
0
N/A
|
18
-4 414%
|
20
-8%
|
14
+27%
|
|
| Total Liabilities & Equity |
1
N/A
|
5
+248%
|
40
+782%
|
21
-47%
|
5
-79%
|
6
+26%
|
14
+149%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
1
|
1
|
3
|
3
|
3
|
4
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
